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Abstract
Background: Intravaginal cleansing may predispose women to adverse health outcomes and may interfere with
the effectiveness and safety of female-initiated methods for preventing sexually transmitted infections (STIs). In
a 4-week randomized study of 192 Malagasy sex workers, we evaluated associations between self-reported
intravaginal cleansing and randomization assignment: diaphragm with viscous candidate microbicide gel
(Acidform, TOPCAD, Chicago, IL, licensed to Instead, Coppell, TX), diaphragm with placebo hydroxyethyl-
cellulose gel (HEC, ReProtect LLC, Baltimore, MD), Acidform alone, or HEC alone.
Methods: Women were counseled to avoid intravaginal cleansing and were blinded to gel assignment. We
evaluated changes in self-reported intravaginal cleansing across the study and assessed the effects of treatment
assignment and covariates on frequent (more than once daily) intravaginal cleansing. Significant predictors in
domain-specific models were evaluated in an all-domain multiple regression model.
Results: The proportion of women reporting intravaginal cleansing decreased from baseline (97%) to week 1
(82%) ( p< 0.001). Self-reported frequent intravaginal cleansing decreased from baseline (87% to 56%) during the
same time period ( p< 0.001). In adjusted analyses, the Acidform-diaphragm group had 60% lower odds of
frequent intravaginal cleansing during the study (odds ratio [OR] 0.4, 95% confidence interval [CI] 0.2-0.8)
compared to the control group (HEC only). HEC-diaphragm and Acidform only users did not differ from
controls. Living on the coast of Madagascar, not cohabiting, frequent intravaginal cleansing at enrollment, and
high coital frequency predicted frequent intravaginal cleansing during follow-up.
Conclusions: Gel characteristics and the diaphragm’s presence likely influenced women’s cleansing. Viscous gel
delivered by a cervical barrier (such as a diaphragm) may minimize the likelihood of frequent intravaginal
cleansing.
Introduction
Intravaginal cleansing includes wiping the vagina withfingers or other objects or substances. It also includes
douching, which is the pressurized application of water or
another liquid into the vagina. Common motivations for
cleansing include personal hygiene (e.g., cleaning after men-
struation or sex), desire to meet the expectations of sexual
partners, pregnancy prevention, and prevention or self-
treatment of vaginal discharge or sexually transmitted infec-
tions (STI).1,2 Women who cleanse intravaginally may disrupt
their vaginal environment in ways that predispose them to
adverse health outcomes. Douching, for example, has been
linked to pelvic inflammatory disease (PID), ectopic preg-
nancy, preterm birth, low birth weight, bacterial vaginosis
(BV), candidiasis, and STIs.3–6 In addition to being a condition
of concern in its own right, BV is a risk factor for preterm birth
and low birth weight.3 BV may also place women at increased
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risk for HIV7 and herpes simplex virus type 2 (HSV-2) infec-
tion.8 It is important to note, however, that data about the
effect of intravaginal cleansing on women’s health are in-
consistent and difficult to interpret.2,4 Indeed, some stud-
ies(e.g.,9) have suggested that particular forms of cleansing
may be beneficial.
Until recently, studies of cervical barriers and microbicides
for HIV=STI prevention have yielded discouraging re-
sults.10,11 The Methods for Improving Reproductive Health in
Africa (MIRA) trial, a large-scale randomized controlled trial
(RCT) of the diaphragm with lubricant gel for HIV pre-
vention, did not demonstrate effectiveness against HIV12 or
cervical STIs13 in intent-to-treat analyses. It has been hy-
pothesized, however, that differential condom use between
treatment arms and less than optimal adherence to dia-
phragm use may have biased results toward the null. No-
tably, per-protocol analyses of data from the MIRA study
suggested an effect against Neisseria gonorrhoeae.13 Although
the results of the MIRA study dampened enthusiasm for
cervical barriers as methods of HIV=STI prevention, it and
other studies demonstrated that the diaphragm may be ac-
ceptable in sub-Saharan Africa.14,15 In light of the debate
about the meaning of the MIRA trial’s results, additional trials
of cervical barriers as methods for STI prevention may still be
warranted. As for microbicides, early studies of non-oxynol-9
generated concerns about increased susceptibility to HIV in-
fection.11 Two RCTs of the candidate microbicide cellulose
sulfate gel were halted because of safety concerns in one of the
studies.16,17 Another candidate microbicide, BufferGel, failed
to show an effect against HIV in a large RCT, whereas PRO
2000 gel showed signs of effectiveness against HIV in the
same trial.18 In 2010, CAPRISA 004 study investigators re-
leased groundbreaking results demonstrating the effective-
ness of tenofovir gel against HIV acquisition.19
Intravaginal cleansing may interfere with the safety and
effectiveness of female-initiated methods, such as micro-
bicides2,20 and cervical barriers. Diaphragms and other cer-
vical barriers may become dislodged as a result of cleansing,
potentially allowing exposure of the cervix to semen and
sexually transmitted pathogens during intercourse. Ad-
ditionally, women who cleanse intravaginally may be less
consistent in their use of cervical barriers compared to wo-
men who do not cleanse intravaginally.21 If a microbicide is
even partially removed through vaginal cleansing, this may
diminish its effect. Furthermore, substances inserted into
the vagina for cleansing may interact with microbicides in
detrimental ways.2
There has been substantial discussion of the importance of
women’s intravaginal practices in the context of microbicide
use,2,22 and some studies have evaluated the relationship
between intravaginal practices and the use of other female-
initiated methods for STI prevention, such as the
diaphragm.(e.g., 23) Nevertheless, there remains a need for in-
formation about the effect of intravaginal practices on the
safety and efficacy of female-initiated methods for STI pre-
vention and, conversely, the effect of these methods on in-
travaginal practices. Using data from a 4-week randomized,
prospective study among female sex workers in Madagascar
(a setting with a high prevalence of intravaginal cleansing24),
we examined the effects of four treatment assignments, in-




From September 2005 to November 2005, we conducted
a randomized pilot study in health clinics in four cities in
Madagascar (Antananarivo, Antsiranana, Mahajanga, and
Toamasina) to assess the feasibility and acceptability of con-
ducting a large-scale RCT of the diaphragm with candidate
microbicide for the prevention of N. gonorrhoeae and Chlamy-
dia trachomatis infection.25 Enrollment criteria included being
aged 15–55 years, not being pregnant and not intending to
become pregnant in the next 2 months, reporting 4 sex
partners in the past month, reporting <100% condom use in
the past 2 weeks, not reporting an allergy to latex, and having
no physical abnormalities precluding diaphragm use.
Each participant was randomly assigned to one of the fol-
lowing: (1) candidate microbicide gel (Acidform, TOPCAD,
Chicago, IL, licensed to Instead, Coppell, TX) applied once
daily in the dome of the latex All-flex Arcing Spring Dia-
phragm (Ortho-McNeil Pharmaceutical, Inc., Titusville, NJ),
(2) inert placebo hydroxyethylcellulose gel (HEC) (ReProtect
LLC, Baltimore, MD) applied once daily in the dome of the
latex All-flex Arcing Spring Diaphragm, (3) Acidform gel
applied intravaginally before every act of sex, and (4) HEC gel
applied intravaginally before every act of sex (the control
group). Acidform is a viscous candidate microbicide gel with
acid-buffering and bioadhesive properties.26 Block randomi-
zation ensured an equal number of participants in each
treatment group at each study site. Sequenced opaque enve-
lopes containing treatment assignments were provided to the
four sites. As each eligible participant was consented and
enrolled, a study clinician at the site opened the next envelope
in the sequence, revealing the participant’s treatment assign-
ment. The study was partially masked; neither participants
nor study staff knew which gel each participant received.
Face-to-face structured interviews and pelvic examinations
were conducted at enrollment and at 4 weekly follow-up visits.
During pelvic examinations, participants were instructed not to
cleanse their internal genitalia while enrolled in the study, and
they were counseled accordingly. Participants were provided
with sufficient supplies of condoms and counseled to use
condoms for every act of sex. To minimize social desirability
bias, we conducted face-to-face interviews before pelvic ex-
aminations and counseling, we trained interviewers to ask
about intravaginal cleansing and other sensitive behaviors in a
nonjudgmental fashion, and we provided counseling of similar
duration and intensity to women in all study groups.
Procedures were approved by the ethics committee of the
Ministry of Health in Antananarivo, Madagascar, and insti-
tutional review boards at the University of North Carolina at
Chapel Hill, North Carolina, and the Centers for Disease
Control and Prevention (CDC) in Atlanta, Georgia.
Measures
Although the main outcomes of this study were acceptabil-
ity and adherence to use of study products during sex, we
planned a priori to conduct an analysis of intravaginal cleansing
during follow-up. Throughout follow-up, women were asked
to report on their typical frequency of intravaginal cleansing in
the past week during the structured face-to-face interview.
Women who chose the response ‘‘not at all’’ were considered to
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have refrained from intravaginal cleansing. Our outcome var-
iable for this analysis, frequent intravaginal cleansing, was
defined as choosing the response ‘‘more than once daily.’’ We
focused on frequent cleansing because there were sufficient
numbers of women reporting this for a robust multivariable
regression analysis; lack of variability in the data precluded a
robust comparison of cleansers to noncleansers.
Our primary predictor variable was treatment assignment
as randomized. Other variables were grouped into three do-
mains: (1) study site and demographic factors, (2) sexual=
reproductive factors, and (3) factors related to product use
and interpersonal power=control. Demographic factors in-
cluded age (quartile), cohabitation=marriage status (three
categories), years of education (above=below the median),
income from a source other than sex work (yes=no), ever re-
ceived more money for not using a condom (yes=no),
crowding in the home (three categories based on sharing of
living quarters), and possession of household items consid-
ered indicative of higher socioeconomic status (SES) (elec-
tricity, television, refrigerator, cell phone, tap water, and flush
toilet). Sexual=reproductive factors included coital frequency
in the past week (tertile), sex with a main partner in the past
week (yes=no), number of sex partners in a typical week
(tertile), percentage of partners who are new in a typical week
(quartile, with middle two quartiles combined), self-reported
consistent condom use in the past week (100% vs. <100%),
hormonal contraception at last sex act (yes=no), gravidity
(quartile), having ever been told by a clinician that she had an
STI (yes=no), clinician-assessed vaginal discharge at previous
study visit, self-reported frequency of intravaginal cleansing
at enrollment (quartile), and knowledge that douching cannot
prevent pregnancy or STI (yes=no). Variables related to
product use and interpersonal power=control included self-
reported adherence to study product use during sex in the
past week (100% vs. <100%), perceived control over condom
use with clients (three categories representing increasing
control), having ever refused a client because he would not
use a condom (yes=no), any client having ever been violent
because of a condom request (yes=no), and perceived im-
portance of preventing main partners from learning of study
products (three categories representing increasing impor-
tance). Variables assessed during follow-up (coital frequency,
sex with a main partner, condom use, vaginal discharge, ad-
herence to study product use, and perceived importance of
main partners not learning of study products) were treated as
time varying.
Statistical analyses
To assess bivariable associations, we entered each predictor
variable into an unadjusted logistic regression model of fre-
quent intravaginal cleansing. We used generalized estimating
equations (GEE) to account for repeated measurements on the
same participant. We then entered predictor variables into
domain-specific logistic regression models (one for each do-
main). We conducted manual backward elimination on each
domain-specific model until all remaining variables were
significant at alpha of 0.20. Significant predictors in domain-
specific models were evaluated in an all-domain multiple
regression model. We again conducted manual backward
elimination, this time at alpha of 0.05. Using domain-specific
models to identify candidate variables for final models can be
helpful when one wishes to limit the number of variables
under consideration at any one time. This approach has been
applied in various contexts.(e.g., 27)
We adjusted domain-specific models and all subsequent
models for study visit (a proxy for change over time), treat-
ment assignment, and site. Based on a priori theoretical con-
siderations (e.g., the role that coital frequency could play
in determining if women cleanse intravaginally), we also
adjusted for coital frequency and adherence to study prod-
uct use during sex. We tested all variables in our final
main effects model for first-order interactions (at alpha¼ 0.05)
between each predictor variable and the following indepen-
dent variables: treatment assignment, site, and coital
frequency.
Finally, to address the possibility that our findings about
the effect of treatment assignment were driven by differential
adherence, we conducted a sensitivity analysis in which we
restricted our final main effects model to weeks of follow-up
for which women reported consistent (100%) use of study
products during sex. Because the regression model for our
sensitivity analysis would not converge when we used GEE,
we did not adjust for repeated measurements in that model. In
all other regression models, however, we used GEE to account
for repeated measurements on the same participants, and we
specified an unstructured working correlation matrix. All
analyses were conducted in SAS (SAS Institute, version 9.1.3,
Cary, NC).
Results
Among 314 women, 192 (61%) met eligibility criteria for the
pilot study and were enrolled. Women were most commonly
found ineligible because they reported consistent condom use
(37%), had <4 sexual partners (25%), were pregnant or plan-
ned to become pregnant (15%), or had an allergy to latex
(11%). The analytic sample for the present analysis consisted
of participants who provided data on intravaginal cleansing
and use of their assigned study products. These 189 partici-
pants contributed 752 weeks of follow-up data (4 weeks of
data were missing).
Baseline characteristics and differences
between groups
Participant characteristics at enrollment are shown in
Table 1. Relatively few (12%) were cohabiting with a husband
or other partner. Less than half (41%) said they had a main sex
partner (husband or boyfriend). About half (48%) said they
always or almost always used condoms with clients. Median
values for coital frequency and total number of partners in a
typical week were 10 (interquartile range [IQR] 8.5) and 7
(IQR 5), respectively.
Compared to other women, HEC only participants were
most often divorced, separated, or widowed. They were also
the most likely to have a main partner. Acidform-diaphragm
participants most often had electricity plus other household
items indicative of higher SES. They had higher sexual fre-
quency and more partners than women in other groups. HEC-
diaphragm participants tended to be younger. Women in the
HEC only and Acidform only groups reported higher levels of
condom use. At baseline, HEC-diaphragm and Acidform only
participants were most often in the highest category of intra-
vaginal cleansing.
DIAPHRAGM, MICROBICIDE, AND VAGINAL CLEANSING 189
Intravaginal cleansing at enrollment
At enrollment, the median number of acts of intra-
vaginal cleansing in the past week was 21 (IQR 14). Of
women who reported intravaginal cleansing in the past
week (97%), nearly all (99%) reported the use of water.
Soap (5%), disinfectant (2%), detergent (2%), permanga-
nate (2%), alum (1%), and lemon (<1%) were less com-
monly used. Among women who reported inserting
an object during cleansing (98% of those who cleansed),
Table 1. Participant Characteristics at Enrollment
Treatment assignment
Diaphragm with Acidform Diaphragm with HEC Acidform only HEC only
Characteristic n (%) n (%) n (%) n (%) pa
Age, years
36þ 14 (31.1) 11 (22.9) 18 (37.5) 14 (29.2) 0.003
29–35 8 (17.8) 7 (14.6) 9 (18.8) 9 (18.8) –
24–28 8 (17.8) 15 (31.3) 8 (16.7) 14 (29.2) –
<24 15 (33.3) 15 (31.3) 13 (27.1) 11 (22.9) –
Marital status
Cohabitation=married 6 (13.3) 5 (10.4) 5 (10.4) 6 (12.5) 0.04
Divorced=separated=widowed 21 (46.7) 19 (39.6) 18 (37.5) 24 (50) –
Never married 18 (40) 24 (50) 25 (52.1) 18 (37.5) –
Education, years
5.5 24 (53.3) 23 (47.9) 25 (52.1) 23 (47.9) 0.71
<5.5 21 (46.7) 25 (52.1) 23 (47.9) 25 (52.1) –
Household items
No electricity 20 (44.4) 18 (37.5) 19 (39.6) 21 (43.8) <0.001
Electricity only 3 (6.7) 11 (22.9) 10 (20.8) 6 (12.5) –
Electricity plus other itemb 22 (48.9) 19 (39.6) 19 (39.6) 21 (43.8) –
Sex acts, typical weekc
15þ 15 (33.3) 11 (22.9) 12 (25.5) 9 (18.8) <0.001
10–14 12 (26.7) 12 (25.0) 12 (25.5) 13 (27.1) –
6–9 15 (33.3) 17 (35.4) 12 (25.5) 13 (27.1) –
<6 3 (6.7) 8 (16.7) 11 (23.4) 13 (27.1) –
Have main partner
Yes 18 (40) 18 (37.5) 17 (35.4) 25 (52.1) 0.004
No 27 (60) 30 (62.5) 31 (64.6) 23 (47.9)
Sex partners, typical weekd
10þ 21 (46.7) 15 (31.3) 16 (33.3) 16 (33.3) 0.01
5–9 16 (35.6) 21 (43.8) 23 (47.9) 20 (41.7) –
4 8 (17.8) 12 (25.0) 9 (18.8) 12 (25.0) –
Typical condom use with clients
Always=almost always 20 (44.4) 19 (39.6) 26 (54.2) 25 (52.1) 0.02
Never=rarely=sometimes 25 (55.6) 29 (60.4) 22 (45.8) 23 (47.9) –
Hormonal contraception at last sex
Yes 12 (26.7) 10 (20.8) 12 (25) 10 (20.8) 0.55
No 33 (73.3) 38 (79.2) 36 (75) 38 (79.2) –
Gravidity
4þ 16 (35.6) 15 (31.3) 18 (37.5) 17 (35.4) 0.11
3 10 (22.2) 6 (12.5) 9 (18.8) 11 (22.9) –
2 9 (20.0) 12 (25.0) 11 (22.9) 9 (18.8) –
0–1 10 (22.2) 15 (31.3) 10 (20.8) 11 (22.9) –
Ever told by clinician that she had STI
Yes 16 (36.4) 18 (37.5) 22 (46.8) 21 (44.7) 0.14
No 28 (63.6) 30 (62.5) 25 (53.2) 26 (55.3) –
Intravaginal cleansing frequency, past week
28þ times 11 (24.4) 17 (35.4) 17 (35.4) 15 (31.3) <0.001
21–27 times 13 (28.9) 11 (22.9) 10 (20.8) 16 (33.3) –
14–20 times 14 (31.1) 14 (29.2) 9 (18.8) 7 (14.6) –
<14 times 7 (15.6) 6 (12.5) 12 (25.0) 10 (20.8) –
Due to rounding and missing data, not all categories sum to 100%.
ap value for Cochran-Mantel-Haenszel test of general association.
bTelevision, refrigerator, cell phone, tap water, or flush toilet.
cMedian 10; interquartile range 8.5.
dMedian 7; interquartile range 5.
HEC, hydroxyethylcellulose gel; STI, sexually transmitted infection.
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fingers (98%) and cloth (98%) were the objects most com-
monly used.
Changes in intravaginal cleansing during follow-up
The percentage of women reporting any intravaginal
cleansing dropped from 97% at enrollment to 82% at week 1
( p< 0.001) (Fig. 1). It continued to drop in the Acidform-
diaphragm and HEC-diaphragm groups but not in other
groups. At week 3, significantly fewer women in the two di-
aphragm groups reported intravaginal cleansing (compared
to women who did not receive a diaphragm) (70% vs. 82%,
p¼ 0.04). This difference did not achieve statistical signifi-
cance at week 4 (67% vs. 77%, p¼ 0.14). Self-reported frequent
(>once daily) intravaginal cleansing dropped from 87% at
enrollment to 56% at week 1 ( p< 0.001). The percentage re-
porting frequent cleansing then leveled off for three of the four
treatment groups but continued to drop within the Acidform-
diaphragm group (Fig. 2). Compared to others, Acidform-
diaphragm participants less often reported frequent cleansing
at week 3 (30% vs. 56%, p¼ 0.03) and week 4 (32% vs. 51%,
p¼ 0.002).
Predictors of intravaginal cleansing during follow-up
Several variables achieved statistical significance in unad-
justed models. Study site, the presence of electricity in the
home (in the absence of other household items indicative of
higher SES), coital frequency, number of partners in a typical
week, percentage of partners who are new in a typical week,
hormonal contraception use at last sex act, self-reported fre-
quency of intravaginal cleansing at baseline, belief that
douching can prevent pregnancy or STI, and violence from a
client after a condom request were all positively associated
with frequent intravaginal cleansing during the study. Edu-
cational attainment, cohabitation, crowding in the home, re-
ceipt of more money for sex without a condom, perceived
control over condom use with clients, and refusal of sex
without a condom were inversely associated with frequent
intravaginal cleansing.
FIG. 1. Percentage of participants
reporting any intravaginal cleansing
at baseline and throughout
follow-up. HEC, hydro-
xyethylcellulose gel.
FIG. 2. Percentage of participants
reporting frequent (>1 time daily)
intravaginal cleansing at baseline
and throughout follow-up.
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Although not significant in unadjusted analyses, treatment
assignment was statistically significant in the final all-domain
model. Assignment to the Acidform-diaphragm group was
associated with 60% lower odds of reporting frequent
intravaginal cleansing during follow-up (odds ratio [OR] 0.4,
95% confidence interval [CI] 0.2-0.8) compared to the HEC
only group (Table 2). For HEC-diaphragm and Acidform only
participants, the odds of frequent cleansing did not differ
significantly from those of HEC only participants.
Other statistically significant variables in the final all-
domain model included study site, marital=cohabitation
status, coital frequency, and self-reported frequency of in-
travaginal cleansing at baseline. Living in Mahajanga was
associated with nearly 40 times the odds of cleansing fre-
quently compared with the reference category of living in
Antananarivo. Residence in Toamasina and Antsiranana was
associated with 18 times and 3 times the odds of frequent
cleansing, respectively. Notably, the CIs for the estimated ORs
for residence in Mahajanga and Toamasina were wide, indi-
cating imprecision. Compared with women currently living
with a partner, ever-married noncohabiting women had more
than twice the odds of reporting frequent cleansing; never-
married noncohabiting women had more than three times the
odds of reporting frequent cleansing. Women in the highest
category of coital frequency had nearly twice the odds of re-
porting frequent cleansing compared with those in the lowest
category. Those in the highest category of intravaginal
cleansing at baseline had 2.5 times the odds of reporting fre-
quent cleansing during the study compared with those in the
lowest category.
Neither consistent condom use nor adherence to study
product use in the past week emerged as a predictor of fre-
quent intravaginal cleansing. All tests for interaction were
nonsignificant.
The sensitivity analysis relied on 321 weeks of follow-up
data. Assignment to the Acidform-diaphragm group was
significantly associated with 80% lower odds of reporting
frequent intravaginal cleansing compared to the HEC only
group (OR 0.2, 95% CI 0.1-0.7).
Discussion
In this randomized prospective study, we evaluated the
effect of receipt of four product combinations on frequent
intravaginal cleansing: the diaphragm with candidate mi-
crobicide gel (Acidform), the diaphragm with placebo gel
(HEC), Acidform alone, and HEC alone. We found that wo-
men whose gel was viscous and delivered by a diaphragm
(i.e., women in the Acidform-diaphragm group) were
most successful in avoiding frequent intravaginal cleansing
during the study. Other predictors of frequent cleansing in-
cluded living in coastal areas of Madagascar (Mahajanga,
Toamasina, and Antsiranana), reporting frequent in-
travaginal cleansing at enrollment, and reporting high coital
frequency during the study; cohabiting with a male partner
was inversely related to frequent cleansing.
Table 2. Bivariable and Multivariable Associations for Predictors
of Frequent Intravaginal Cleansing During Follow-Up
Visits at which women reported
frequent cleansing Bivariable Multivariable
Characteristic n (%) OR (95% CI) OR (95% CI)
Treatment assignment
Diaphragm with Acidform 71 (40.1) 0.56 (0.30-1.05) 0.37 (0.16-0.84)
Diaphragm with HEC 104 (54.2) 0.93 (0.49-1.79) 0.97 (0.48-1.95)
Acidform only 110 (57.6) 1.08 (0.56-2.08) 1.14 (0.60-2.17)
HEC only (referent) 106 (55.2) 1 1
Site
Mahajanga 160 (85.1) 42.54 (19.30-93.77) 37.3 (16.35-85.12)
Toamasina 145 (75.5) 22.63 (11.46-44.68) 17.84 (8.02-39.69)
Antsiranana 64 (35.6) 4.10 (2.18-7.70) 3.12 (1.50-6.45)
Antananarivo (referent) 22 (11.5) 1 1
Cohabitation=marriage
Never married, noncohabiting 210 (62.3) 7.50 (3.34-16.84) 3.41 (1.16-9.97)
Ever married, noncohabiting 166 (50.8) 4.93 (2.19-11.08) 2.44 (0.88-6.76)
Cohabiting (referent) 15 (17.1) 1 1
Coital frequency, past week
18þ 161 (63.6) 1.69 (1.20-2.39) 1.80 (1.10-2.96)
11–17 132 (50.6) 1.21 (0.88-1.66) 1.35 (0.84-2.18)
<11 (referent) 98 (41.2) 1 1
Intravaginal cleansing at enrollment, past week
28þtimes 146 (61.9) 2.56 (1.27-5.17) 2.52 (1.17-5.41)
21–27 times 105 (52.5) 1.74 (0.85-3.56) 1.93 (0.92-4.07)
14–20 times 82 (46.6) 1.38 (0.66-2.88) 1.73 (0.72-4.15)
<14 times (referent) 58 (41.4) 1 1
Generalized estimating equations (GEE) were used to account for repeated measurements on the same participant. Multivariable ORs and
CIs reflect adjustment for all variables presented here plus study visit and adherence to study product use during sex.
CI, confidence interval; OR, odds ratio.
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Little has been published about intravaginal practices in
Madagascar. A mixed-method study conducted among sex
workers in Antananarivo, Toamasina, and Mahajanga re-
vealed that participants generally cleansed intravaginally
with their forefinger and water whenever they bathed and
between clients.24 A qualitative study conducted at a public
clinic in Antananarivo28 found that women considered in-
travaginal cleansing necessary to remove impurities before
and after sex. Additionally, women believed that their male
partners would be displeased if they failed to cleanse before
sex. In the present study, anecdotal reports from the field
revealed that some women found the added moisture from
study gels uncomfortable and that some were concerned that
men would confuse the gels with ejaculate from previous
partners.
We consider it likely that the presence of a diaphragm and
the physical characteristics of the gels influenced women’s
choices about intravaginal cleansing. Gels may have been
sensed as moisture or wetness, and vaginal cleansing may
have been motivated by the volume of gel that was present;
that is, as more gel accumulated in the vagina, women may
have experienced a greater compulsion to cleanse despite
having been instructed not to do so. In the two diaphragm-gel
groups, there would have been comparatively less gel in the
vagina, and we would therefore expect less cleansing.
Nevertheless, we observed lower levels of cleansing in the
Acidform-diaphragm group but not in the HEC-diaphragm
group. HEC is less viscous than Acidform, and it may have
been more likely to leak around the edges of the diaphragm.
Thus, it is possible that women in the HEC-diaphragm group
were exposed to more gel on the exterior (noncervix) side of
the diaphragm and more often sensed an unacceptable degree
of moisture or wetness compared to women in the Acidform-
diaphragm group. In summary, women in the Acidform-
diaphragm group may have been least likely to reach the
point where an unacceptable amount of gel had accumulated,
and this may explain why Acidform-diaphragm participants
had the lowest odds of frequent intravaginal cleansing during
the study.
We considered alternative explanations for our finding that
receipt of a diaphragm with Acidform was inversely associ-
ated with frequent intravaginal cleansing. These included
differential adherence, differential condom use, and differing
expectations of product efficacy. As we reported previously,25
the Acidform-diaphragm group reported somewhat higher
levels of study product use during sex (compared to the
control group of HEC alone). Nevertheless, the results of our
sensitivity analysis do not support differential adherence as
an explanation for our findings. The sensitivity analysis rep-
licated the final model of intravaginal cleansing but included
only weeks of follow-up during which women reported 100%
adherence to study regimens. Results were similar to those of
the main analysis: when self-reported adherence was optimal,
the inverse association between receipt of diaphragm with
Acidform and frequent cleansing remained.
The literature suggests an inverse association between
condom use and intravaginal cleansing.21,29 Although all
groups received equivalent counseling about condom use, we
previously reported that self-reported condom use was low-
est in the Acidform-diaphragm group (62% of acts vs. the
overall average of 66%).25 This would lead us to expect
comparatively more cleansing in the Acidform-diaphragm
group. Thus, differential condom use is an unlikely explana-
tion for our findings.
If study participants believed that intravaginal cleansing
protects women from STI or pregnancy and if expectations of
product efficacy varied by study group, this could have caused
differences between groups in intravaginal cleansing. It is un-
likely that the type of gel received led to differing expectations
of efficacy. Participants were blinded to whether they received
active or placebo gel. Although some women presumably no-
ticed that their gel was thicker or thinner than the alternative,
we have no reason to believe that women knew whether they
had received active or placebo gel. Women in diaphragm arms
may have felt more protected than women who received a gel
alone. Nevertheless, this increased sense of protection would
have led to lower levels of cleansing in both diaphragm groups,
not just the Acidform-diaphragm group.
As for other predictors of frequent cleansing, coastal and
inland regions of Madagascar have different cultural norms
surrounding intravaginal cleansing; intravaginal cleansing is
more strongly encouraged on the coast. Additionally, coastal
areas are less temperate, and the heat and resulting perspi-
ration may increase women’s desires to cleanse. Women who
cleansed frequently before enrolling in the study may have
found it particularly difficult to avoid frequent cleansing
during the study. Our finding that women with the highest
coital frequency cleansed most frequently is consistent with
other research in this population, which found that many
women cleanse intravaginally between clients.24 Cohabiting
with a husband or other sexual partner may afford less pri-
vacy for intravaginal cleansing compared to not sharing living
space with a partner.
Limitations of this study include small sample size, rela-
tively short follow-up, reliance on self-reported data, and ap-
parent imbalance on baseline characteristics. Despite the
limited statistical power that our small sample size afforded,
we identified a significant effect of receiving the diaphragm
with Acidform on frequent cleansing. Although we could not
evaluate the long-term effect of treatment assignment on
cleansing, 4 weeks may have been sufficient for participants to
become accustomed to their study products and adapt their
intravaginal cleansing habits accordingly. Reliance on self-
reported data, which can be subject to recall and social desir-
ability biases, is another limitation. Social desirability is a
plausible explanation for the large overall drops in self-
reported intravaginal cleansing from enrollment to the first
follow-up visit. However, we would not expect differences
between groups in either recall or the social desirability of re-
porting intravaginal cleansing during the study, and, thus, we
do not consider our main findings about predictors of fre-
quent cleansing to have been biased by social desirability. Al-
though some may consider baseline differences among
treatment groups to be a limitation of the study, we would
argue that it is unrealistic to expect balance every time random
selection is implemented30 and that we have likely achieved
better overall balance than we would have with nonrandom
selection.
Strengths of this study include the longitudinal design and,
despite some apparent imbalances among treatment groups,
randomization of study participants. The longitudinal design
allowed us to account for temporality (e.g., by adjusting
regression models for change over time). By randomizing
participants, we reduced the likelihood of substantial
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confounding by women’s measured or unmeasured baseline
characteristics.
Conclusions
Concerns have been raised about the potential for harmful
effects of intravaginal practices on the safety and effectiveness
of vaginal microbicides and other methods that are used in-
travaginally, such as the diaphragm. Should there be an ad-
verse effect of frequent intravaginal cleansing on microbicide
effectiveness or safety, the mode of microbicide delivery may
influence the likelihood of frequent cleansing and, therefore,
influence the likelihood of harm. Identifying modes of delivery
that make abstaining from cleansing more acceptable may lead
to better outcomes for women. Our results suggest that in a
population in which intravaginal cleansing is prevalent and at
least partially motivated by the desire to regulate the amount of
material in the vagina, women may be more successful in
avoiding frequent intravaginal cleansing if a gel (e.g., a mi-
crobicide) is viscous and delivered by a cervical barrier.
More research is needed on the effects of female-initiated
methods of STI prevention on intravaginal practices. Ad-
ditionally, more research is needed on the impact of in-
travaginal practices on the safety and efficacy of these
methods. Counseling women not to engage in intravaginal
cleansing is a common strategy for preventing cleansing in
research studies of new methods. However, the degree to
which counseling and educational messages can modify
women’s vaginal cleansing habits is uncertain20–22 and re-
quires further study.31 Research studies addressing the safety
and effectiveness of methods that are used intravaginally
should include subanalyses among women who, despite
counseling, cleanse intravaginally. Without a better under-
standing of the safety and efficacy of methods that are used
intravaginally, we may find ourselves unable to recommend
these methods to women who cleanse but, nevertheless, are at
risk of unintended pregnancy and STIs.
Acknowledgments
This study was funded by the U.S. Centers for Disease
Control and Prevention through an interagency agreement
with the U.S. Agency for International Development and
CONRAD. The findings and conclusions in this report are
those of the authors and do not necessarily represent the of-
ficial position of CDC, nor does mention of trade names,
commercial products, or organizations imply endorsement by
the U.S. Government.
Disclosure Statement
No competing financial interests exist.
References
1. Cottrell BH. Vaginal douching. J Obstet Gynecol Neonatal
Nurs 2003;32:12–18.
2. Hilber AM, Chersich MF, van de Wijgert JH, et al. Vaginal
practices, microbicides and HIV: What do we need to know?
Sex Transm Infect 2007;83:505–508.
3. Martino JL, Vermund SH. Vaginal douching: Evidence for
risks or benefits to women’s health. Epidemiol Rev 2002;24:
109–124.
4. Myer L, Kuhn L, Stein ZA, et al. Intravaginal practices,
bacterial vaginosis, and women’s susceptibility to HIV in-
fection: Epidemiological evidence and biological mecha-
nisms. Lancet Infect Dis 2005;5:786–794.
5. Simpson T, Merchant J, Grimley DM, et al. Vaginal douching
among adolescent and young women: More challenges than
progress. J Pediatr Adolesc Gynecol 2004;17:249–255.
6. Ness RB, Hillier SL, Richter HE, et al. Douching in relation to
bacterial vaginosis, lactobacilli, and facultative bacteria in
the vagina. Obstet Gynecol 2002;100:765.
7. St John E, Mares D, Spear GT. Bacterial vaginosis and host
immunity. Curr HIV=AIDS Rep 2007;4:22–28.
8. Cherpes TL, Meyn LA, Krohn MA, et al. Association be-
tween acquisition of herpes simplex virus type 2 in women
and bacterial vaginosis. Clin Infect Dis 2003;37:319–325.
9. Gresenguet G, Kreiss JK, Chapko MK, et al. HIV infection
and vaginal douching in central Africa. AIDS 1997;11:101–
106.
10. Padian NS, McCoy SI, Balkus JE, et al. Weighing the gold in
the gold standard: Challenges in HIV prevention research.
AIDS 2010;24:621–635.
11. Wetmore CM, Manhart LE, Wasserheit JN. Randomized
controlled trials of interventions to prevent sexually trans-
mitted infections: Learning from the past to plan for the
future. Epidemiol Rev 2010;32:121–136.
12. Padian NS, van der Straten A, Ramjee G, et al. Diaphragm
and lubricant gel for prevention of HIV acquisition in
southern African women: A randomised controlled trial.
Lancet 2007;370:251–261.
13. Ramjee G, van der Straten A, Chipato T, et al. The dia-
phragm and lubricant gel for prevention of cervical sexually
transmitted infections: Results of a randomized controlled
trial. PLoS One 2008;3:e3488.
14. Montgomery ET, Cheng H, van der Straten A, et al. Ac-
ceptability and use of the diaphragm and Replens lubricant
gel for HIV prevention in Southern Africa. AIDS Behav
2010;14:629–638.
15. Bukusi EA, Gallo MF, Sharma A, et al. Adherence to dia-
phragm use for infection prevention: A prospective study of
female sex workers in Kenya. Infect Dis Obstet Gynecol
2009;2009:420196. Epub March 7, 2010.
16. Van Damme L, Govinden R, Mirembe FM, et al. Lack of
effectiveness of cellulose sulfate gel for the prevention
of vaginal HIV transmission. N Engl J Med 2008;359:463–
472.
17. Halpern V, Ogunsola F, Obunge O, et al. Effectiveness of
cellulose sulfate vaginal gel for the prevention of HIV in-
fection: Results of a phase III trial in Nigeria. PLoS One
2008;3:e3784.
18. Karim SA, Coletti A, Richardson BA. Safety and effective-
ness of vaginal microbicides BufferGel and PRO 2000 gel for
the prevention of HIV infection in women. Presented at the
16th Conference on Retroviruses and Opportunistic Infec-
tions (CROI), Montreal, Canada, February 8–11, 2009.
19. Abdool Karim Q, Abdool Karim SS, for CAPRISA 004 Trial
Group. Effectiveness and safety of tenofovir gel, an anti-
retroviral microbicide, for the prevention of HIV infection in
women. Science 2010;329:1168–1174.
20. Koblin BA, Mayer K, Mwatha A, et al. Douching practices
among women at high risk of HIV infection in the United
States: Implications for microbicide testing and use. Sex
Transm Dis 2002;29:406–410.
21. van der Straten A, Cheng H, Chidanyika A, et al. Vaginal
practices and associations with barrier methods and gel use
194 PENMAN-AGUILAR ET AL.
among sub-Saharan African women enrolled in an HIV
prevention trial. AIDS Behav 2010;14:590–599.
22. Braunstein S, van de Wijgert J. Preferences and practices
related to vaginal lubrication: Implications for microbicide
acceptability and clinical testing. J Womens Health 2005;
14:424–433.
23. Gallo MF, Sharma A, Bukusi EA, et al. Intravaginal practices
among female sex workers in Kibera, Kenya. Sex Transm
Infect 2010;86:318–322.
24. Behets FM, Van Damme K, Turner AN, et al. Evidence-
based planning of a randomized controlled trial on
diaphragm use for prevention of sexually transmitted in-
fections. Sex Transm Dis 2008;35:238–242.
25. Behets FM, Turner AN, for Mad STI Prevention Group.
Vaginal microbicide and diaphragm use for sexually trans-
mitted infection prevention: A randomized acceptability and
feasibility study among high-risk women in Madagascar.
Sex Transm Dis 2008;35:818–826.
26. Garg S, Anderson RA, Chany CJ, et al. Properties of a new
acid-buffering bioadhesive vaginal formulation (Acidform).
Contraception 2001;64:67–75.
27. Al Habashneh R, Guthmiller JM, Levy S, et al. Factors re-
lated to utilization of dental services during pregnancy. J
Clin Periodontol 2005;32:815–821.
28. Legardy-Williams J, Bell AJ, Jamieson DJ, et al. Attitudes
and beliefs about vaginal cleansing among women, men and
healthcare providers in Antananarivo, Madagascar. Pre-
sented at the Microbicides 2006 Conference. Cape Town,
South Africa, April 23–26, 2006.
29. Scorgie F, Kunene B, Smit JA, et al. In search of sexual
pleasure and fidelity: Vaginal practices in KwaZulu-Natal,
South Africa. Cult Health Sex 2009;11:267–283.
30. Senn S. Testing for baseline balance in clinical trials. Stat
Med 1994;13:1715–1726.
31. McClelland RS, Ndinya-Achola JO, Baeten JM. Re: distin-
guishing the temporal association between women’s in-
travaginal practices and risk of human immunodeficiency
virus infection: A prospective study of South African women
[Letter]. Am J Epidemiol 2007;165:474–475.
Address correspondence to:
Ana Penman-Aguilar, Ph.D.
Women’s Health and Fertility Branch
Division of Reproductive Health
National Center for Chronic Disease Prevention
and Health Promotion
Centers for Disease Control and Prevention
4770 Buford Highway, MS K-34
Atlanta, GA 30341
E-mail: bpv4@cdc.gov
DIAPHRAGM, MICROBICIDE, AND VAGINAL CLEANSING 195

